Hirsch David 4
4 · Poseida Therapeutics, Inc. · Filed Jul 26, 2021
Insider Transaction Report
Form 4
Hirsch David
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-23+25,833→ 25,833 totalExercise: $8.63Exp: 2031-07-23→ Common Stock (25,833 underlying)
Footnotes (1)
- [F1]The stock option will vest and become exercisable on the earlier to occur of (i) June 16, 2022 and (ii) the day preceding the date of the 2022 annual meeting of the Issuer's stockholders.